Antibodies and immunotoxins that target human glycoprotein NMB

Details for Australian Patent Application No. 2006308648 (hide)

Owner The Government of the United States, as represented by The Secretary of Health and Human Services, National Institutes of Health Duke University

Inventors Kuan, Chien-Tsun; Bigner, Darell D.; Pastan, Ira H.

Agent Freehills

Pub. Number AU-A-2006308648

PCT Pub. Number WO2007/053718

Priority 60/732,227 31.10.05 US

Filing date 31 October 2006

Wipo publication date 10 May 2007

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 51/10 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 35/00 (2006.01) Antineoplastic agents

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

22 May 2008 PCT application entered the National Phase

  PCT publication WO2007/053718 Priority application(s): WO2007/053718

25 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006308655-Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties

2006308635-Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion